To consider and approve the audited standalone and consolidated financial results for the quarter and year ended on March 31, 2025.
PATANJALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Patanjali Foods' Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with auditors (Chaturvedi & Shah LLP) issuing an unmodified opinion. Standalone revenue from operations grew about 7.6% YoY to Rs. 34,157 crore, while profit after tax jumped roughly 70% to Rs. 1,301 crore, and EPS rose to Rs. 35.99 from Rs. 21.14. Q4 standalone revenue rose about 18% YoY to Rs. 9,692 crore with PAT nearly 74% higher at Rs. 358.5 crore. The Board recommended a final dividend of Rs. 2 per share, taking total FY25 dividend to Rs. 10 per share (Rs. 8 interim already paid). A new Home & Personal Care segment was added following the Rs. 1,100 crore slump-sale acquisition from Patanjali Ayurved, effective November 1, 2024. The Company is also challenging an arbitration award directing it to issue 1.87 crore equity shares to Ashav Advisory LLP before the Delhi High Court.
Strong profit growth, margin expansion, and a Rs. 10 total dividend for FY25 are positive for shareholders. The non-food business acquisition diversifies revenue beyond edible oils, but the ongoing arbitration case over a potential large share issuance remains a key risk to monitor.